...
机译:NCCTG和NABTC联合对高级别复发性神经胶质瘤的预后因素分析
Mayo Clinic and Mayo Foundation, Rochester, Minnesota Division of Biostatistics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905;
Department of Neurological Surgery, University of California, San Francisco, San Francisco, California;
Mayo Clinic and Mayo Foundation, Rochester, Minnesota;
Mayo Clinic and Mayo Foundation, Rochester, Minnesota;
Department of Neurological Surgery, University of California, San Francisco, San Francisco, California;
Mayo Clinic and Mayo Foundation, Rochester, Minnesota;
Mayo Clinic Florida, Department of Neurology, Jacksonville, Florida;
Department of Neurological Surgery, University of California, San Francisco, San Francisco, California;
brain tumors; high grade; prognostic factors; recurrent glioma;
机译:通过中央病理学检查诊断为患有低度神经胶质瘤的患者的新型经过验证的预后模型和预后计算器:EORTC / RTOG / NCCTG III期临床试验的汇总分析
机译:老年高级别胶质瘤患者的预后因素:24例回顾性分析
机译:进行性高级别神经胶质瘤的再照射:结局,同时化疗的作用,预后因素以及独立患者队列对新预后评分的验证
机译:Gliadel的长期疗效(高级恶性胶质瘤患者的晶片:Meta分析
机译:对流增强了放射增敏剂负载纳米颗粒的治疗,用于治疗高级神经胶质瘤
机译:NCCTG和NABTC联合对高级别复发性神经胶质瘤的预后因素分析
机译:NCCTG和NABTC联合对高级别复发性神经胶质瘤的预后因素分析